7 alpha-hydroxy-4-cholesten-3-one has been researched along with glycosides in 3 studies
| Studies (7 alpha-hydroxy-4-cholesten-3-one) | Trials (7 alpha-hydroxy-4-cholesten-3-one) | Recent Studies (post-2010) (7 alpha-hydroxy-4-cholesten-3-one) | Studies (glycosides) | Trials (glycosides) | Recent Studies (post-2010) (glycosides) |
|---|---|---|---|---|---|
| 134 | 28 | 59 | 20,179 | 169 | 6,844 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Acevedo, L; Dorenbaum, A; Gedulin, B; Keller, BT; Kennedy, CA; Levin, N; Palmer, M; Tiessen, RG; van Vliet, AA | 1 |
| Bliss, C; Jennings, L; Martin, P; Palmer, M; Silberg, DG | 1 |
| Aithal, GP; Freilich, B; Hassanein, T; Herring, R; Kayali, Z; Lee, HM; Mantry, P; Newsome, PN; Palmer, M; Sarles, H; Sheikh, A; Sheikh, MY | 1 |
3 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and glycosides
| Article | Year |
|---|---|
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Benzothiepins; Bile Acids and Salts; Blood Glucose; Cholestenones; Diabetes Mellitus, Type 2; Double-Blind Method; Feces; Female; Glycosides; Homeostasis; Humans; Lipid Metabolism; Male; Membrane Glycoproteins; Middle Aged; Non-alcoholic Fatty Liver Disease; Organic Anion Transporters, Sodium-Dependent; Symporters; Young Adult | 2018 |
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.
Topics: Adult; Benzothiepins; Bile Acids and Salts; Cholestenones; Double-Blind Method; Feces; Female; Glycosides; Healthy Volunteers; Humans; Lipid Regulating Agents; Lipids; Male; Middle Aged; Overweight | 2018 |
Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study.
Topics: Alanine Transaminase; Benzothiepins; Biomarkers; Cholestenones; Cholesterol; Double-Blind Method; Female; Glycosides; Humans; Lipid Regulating Agents; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Organic Anion Transporters, Sodium-Dependent; Patient Acuity; Symporters; Treatment Outcome | 2020 |